US 9713599
Parenteral formulations of treprostinil
granted A61KA61K31/19A61K31/191
Quick answer
US patent 9713599 (Parenteral formulations of treprostinil) held by United Therapeutics Corporation expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Jul 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/19, A61K31/191, A61K31/192, A61K31/201